Publications by authors named "Carole Tarpin"

41Publications

[Impact of Her2 and BRCA1/2 status in high-dose chemotherapy and autologous stem cells transplantation in the treatment of breast cancer: The Institut Paoli Calmettes' experience].

Bull Cancer 2017 Apr 16;104(4):332-343. Epub 2017 Feb 16.

Institut Paoli-Calmettes (IPC), département d'oncologie médicale, 232, boulevard de Sainte-Marguerite, 13009 Marseille cedex 9, France; Centre de recherches en cancérologie de Marseille (CRCM), UMR Inserm 1068/CNRS 7258/AMU 105/IPC, 232, boulevard de Sainte-Marguerite, 13009 Marseille, France; Aix-Marseille université, Jardin du Pharo, 58, boulevard Charles-Livon, 13284 Marseille, France. Electronic address:

View Article and Find Full Text PDF
April 2017

Prognostic impact of hormone receptor- and HER2-defined subtypes in inflammatory breast cancer treated with high-dose chemotherapy: a retrospective study.

J Cancer 2016 23;7(14):2077-2084. Epub 2016 Oct 23.

Aix-Marseille Université, Marseille, F-13284, France.; Centre de Thérapie Cellulaire, Département de Biologie du Cancer, Institut Paoli-Calmettes, Marseille, F-13273, France.; Centre d'Investigations Cliniques en Biothérapies, Inserm CBT-1409, Marseille, F-13009, France.

View Article and Find Full Text PDF
October 2016

Corrigendum to "Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation" [Eur J Cancer 57 (April 2016) 118-126].

Eur J Cancer 2016 11 24;67:223. Epub 2016 Sep 24.

Département d'Oncologie Médicale, Institut Paoli-Calmettes (IPC), Marseille, F-13273, France; Centre de Recherches en Cancérologie de Marseille (CRCM), UMR Inserm 1068/CNRS 7258/AMU 105/IPC, Marseille, F-13009, France; Aix-Marseille Université, Marseille, F-13284, France. Electronic address:

View Article and Find Full Text PDF
November 2016

Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation.

Eur J Cancer 2016 04 23;57:118-26. Epub 2016 Feb 23.

Département d'Oncologie Médicale, Institut Paoli-Calmettes (IPC), Marseille, F-13273, France; Centre de Recherches en Cancérologie de Marseille (CRCM), UMR Inserm 1068/CNRS 7258/AMU 105/IPC, Marseille, F-13009, France; Aix-Marseille Université, Marseille, F-13284, France. Electronic address:

View Article and Find Full Text PDF
April 2016

METRO1: A Phase I Study of Metronomic Chemotherapy in Adults with Advanced Refractory Solid Tumors.

Anticancer Res 2016 Jan;36(1):293-9

Department of Oncology, Institut Paoli-Calmettes, Marseille, France Centre de Recherche en Cancérologie de Marseille, INSERM U1068, CNRS U7258, Marseille, France Aix-Marseille Université, Marseille, France.

View Article and Find Full Text PDF
January 2016

Early discontinuation of tamoxifen intake in younger women with breast cancer: is it time to rethink the way it is prescribed?

Eur J Cancer 2012 Sep 29;48(13):1939-46. Epub 2012 Mar 29.

Department of Cancer Genetics, Prevention and Screening, Institut Paoli-Calmettes, Marseille, France.

View Article and Find Full Text PDF
September 2012

Capecitabine after anthracycline and taxane exposure in HER2-negative metastatic breast cancer patients: response, survival and prognostic factors.

Anticancer Res 2011 Mar;31(3):1079-86

Oncologie Médicale, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille, INSERM U891, 232, boulevard Sainte Marguerite, 13009 Marseille, France.

View Article and Find Full Text PDF
March 2011

Systemic therapy of inflammatory breast cancer from high-dose chemotherapy to targeted therapies: the French experience.

Cancer 2010 Jun;116(11 Suppl):2829-36

Department of Medical Oncology, Paoli-Calmettes Institute, Marseille Cancer Research Center, UMR891 Inserm, IFR137, Marseille, France.

View Article and Find Full Text PDF
June 2010

Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer.

Clin Cancer Res 2010 Jan 22;16(1):45-55. Epub 2009 Dec 22.

Department of Molecular Oncology, Institut Paoli-Calmettes/UMR891 Institut National de la Sante et de la Recherche Medicale, Université de la Méditerranée, Marseille Cancer Research Center, Marseille, France.

View Article and Find Full Text PDF
January 2010

Docetaxel first-line therapy in HER2-negative advanced breast cancer: a cohort study in patients with prospectively determined HER2 status.

Anticancer Drugs 2009 Nov;20(10):946-52

Oncologie Médicale, Centre de Recherche en Cancérologie de Marseille, INSERM U891, Institut Paoli Calmettes, 232, boulevard Sainte Marguerite, Marseille 13000, France.

View Article and Find Full Text PDF
November 2009

Defining the molecular biology of inflammatory breast cancer.

Semin Oncol 2008 Feb;35(1):41-50

Département d'Oncologie Moléculaire, Institut Paoli-Calmettes and UMR599 INSERM, IFR137, 232 Boulevard Sainte-Marguerite, Marseille Cedex 09, France.

View Article and Find Full Text PDF
February 2008

Medullary thyroid cancer treated by capecitabine.

Anticancer Drugs 2007 Aug;18(7):831-4

Department of Medical Oncology, Institut Paoli Calmettes, 232 Boulevard Sainte Marguerite, 13009 Marseille, France.

View Article and Find Full Text PDF
August 2007

Decision-making and breast cancer clinical trials: how experience challenges attitudes.

Contemp Clin Trials 2007 Nov 12;28(6):684-94. Epub 2007 Mar 12.

INSERM, UMR379, Epidemiology and Social Sciences Unit, Paoli-Calmettes Institute, Marseille, F-13273, France.

View Article and Find Full Text PDF
November 2007

Value of the sentinel lymph node procedure in patients with large size breast cancer.

Ann Surg Oncol 2007 Feb 12;14(2):621-6. Epub 2006 Nov 12.

Department of Surgery, Institut Paoli-Calmettes, 232 Bd Sainte Marguerite, Marseilles, France.

View Article and Find Full Text PDF
February 2007

[G-CSF in oncology].

Bull Cancer 2006 May;93(5):463-71

Département d'oncologie médicale, Institut Paoli-Calmettes, 232, boulevard Sainte-Marguerite, 13273 Marseille Cedex 09.

View Article and Find Full Text PDF
May 2006

Gene expression profiling identifies molecular subtypes of inflammatory breast cancer.

Cancer Res 2005 Mar;65(6):2170-8

Institut de Cancérologie de Marseille, Laboratoire d'Oncologie Moléculaire, Institut Paoli-Calmettes and UMR599 Institut National de la Santé et de la Recherche Médicale, IFR137, France.

View Article and Find Full Text PDF
March 2005